About this trial
This randomized controlled trial aims to compare the effects of alternating altitude training and fixed-altitude training on physical performance and physiological adaptations in elite race walkers living at altitude. Elite race walkers from Yunnan Province will be randomly assigned to either an alternating altitude training group or a fixed-altitude training group. The alternating altitude training group will perform selected training sessions under simulated higher-altitude conditions while completing the remaining sessions at their regular altitude training base. The fixed-altitude training group will complete all training sessions at the regular altitude. Physical performance, race walking performance, cardiovascular function, pulmonary function, and hematological parameters will be assessed before and after the intervention to evaluate the effectiveness of the two altitude training strategies.
Eligibility criteria
This trial accepts healthy volunteersQualifiers
Male and female elite race walkers aged 16-26 years. Registered athletes from the Yunnan Provincial Race Walking Team. Long-term residents of high-altitude regions with regular altitude training experience.
Disqualifiers
Any cardiovascular, respiratory, metabolic, neurological, or other medical condition contraindicating exercise or hypoxic exposure.
Trial design
Parallel
Treatments tested in this trial
Alternating Altitude Training
BehavioralParticipants complete the prescribed training program using an alternating altitude strategy, combining regular altitude training with selected sessions performed under simulated higher-altitude conditions.
Fixed-Altitude Training
BehavioralParticipants complete the prescribed training program exclusively at the regular altitude training base.
Treatment groups
Trial outcomes
Primary outcomes
Body Weight
Body weight measured before and after the training period.
Body Fat Percentage
Body fat percentage measured using bioelectrical impedance or other validated method.
Forced Vital Capacity (FVC)
Forced vital capacity measured using spirometry before and after the intervention.
Maximal Voluntary Ventilation
MVV measured using standard pulmonary function testing protocol pre- and post-intervention.
Secondary outcomes
Red Blood Cell Count
RBC count measured from venous blood samples pre- and post-intervention.
Hemoglobin
Hemoglobin concentration measured from venous blood samples.
Hematocrit
Hemoglobin concentration measured from venous blood samples.
Erythropoietin
Plasma EPO concentration measured from venous blood samples.
Sponsors and contacts
Click on the lead sponsor to view all of their trials.